GlassScriptPhysician profile
James H Cook
NPI 1679677074
$5,000.83
in general payments reported to CMS, 2019-2025
56 companies · $936 in 2025
The $936 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $480 · 2021: $185 · 2022: $958 · 2023: $729 · 2024: $605 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,158 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,157.55 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $877.47 | 2019-2025 | Qulipta, Ubrelvy |
| Argenx US, INC. | $470.56 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Teva Pharmaceuticals USA, INC. | $263.89 | 2019-2025 | Ajovy, Austedo |
| Lundbeck LLC | $195.79 | 2019-2025 | Vyepti, Rexulti |
| Medtronic USA, INC. | $188.00 | 2019 | |
| Acorda Therapeutics, INC | $151.95 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $150.63 | 2019-2024 | Ultomiris |
| Akcea Therapeutics, INC. | $122.23 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $121.81 | 2022 | |
| Sunovion Pharmaceuticals INC. | $118.50 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $110.97 | 2023-2024 | Aptiom |
| Mdd US Operations, LLC | $107.10 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $99.24 | 2023-2025 | Rexulti |
| Merz Pharmaceuticals, LLC | $97.48 | 2022-2025 | Inbrija |
| Ucb, INC. | $94.41 | 2019-2022 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.